A randomized controlled trial to investigate the use of acute coronary syndrome therapy in patients hospitalized with COVID-19: the COVID-19 Acute Coronary Syndrome trial — Alexandra N. Nowbar (2023) | RDL Network
A randomized controlled trial to investigate the use of acute coronary syndrome therapy in patients hospitalized with COVID-19: the COVID-19 Acute Coronary Syndrome trial
Article 2023 en
Authors
AN
Alexandra N. Nowbar
AK
Amit Kaura
MM
Myril Mariveles
Abstract
1 min read
Acute coronary syndrome treatment regimen was associated with a reduction in the length of hospital stay without an excess in major bleeding. A larger trial is needed to evaluate mortality.
M.C. Nguyen, Yu Liang Lim, Antony Walton, Jeffrey Lefkovits, Giancarlo Agnelli, Shaun G. Goodman, Andrzej Budaj, Dietrich C. Gulba, Jeanna Allegrone, David Brieger
M. J. Ng Kam Chuen, Rebecca Schofield, Rajiv Sankaranarayanan, Christopher Crowe, Karen M. Helm, Deirdre A. Lane, Ravi Singh, John E. McDonald, Kanarath Balachandran
Michelle L. O’Donoghue, Eugene Braunwald, Harvey D. White, Patrick W. Serruys, Philippe Gabríel Steg, Judith S. Hochman, Aldo P. Maggioni, Christoph Bode, Donald W. Weaver, Joel L. Johnson, Greg Cicconetti, Mary Ann Lukas, Elizabeth Tarka, Christopher P. Cannon
Discussion(0)
No comments yet. Be the first to comment.